Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study

BACKGROUND: The predictive value of serum neurofilament light chain (sNfL) on long-term prognosis in multiple sclerosis (MS) is still unclear. OBJECTIVE: Investigate the relation between sNfL levels over a 2-year period in patients with relapsing-remitting MS, and clinical disability and grey matter...

Descripción completa

Detalles Bibliográficos
Autores principales: Lie, Ingrid Anne, Kaçar, Sezgi, Wesnes, Kristin, Brouwer, Iman, Kvistad, Silje S, Wergeland, Stig, Holmøy, Trygve, Midgard, Rune, Bru, Alla, Edland, Astrid, Eikeland, Randi, Gosal, Sonia, Harbo, Hanne F, Kleveland, Grethe, Sørenes, Yvonne S, Øksendal, Nina, Varhaug, Kristin N, Vedeler, Christian A, Barkhof, Frederik, Teunissen, Charlotte E, Bø, Lars, Torkildsen, Øivind, Myhr, Kjell-Morten, Vrenken, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304101/
https://www.ncbi.nlm.nih.gov/pubmed/35649699
http://dx.doi.org/10.1136/jnnp-2021-328568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304101/
https://www.ncbi.nlm.nih.gov/pubmed/35649699
http://dx.doi.org/10.1136/jnnp-2021-328568

Ejemplares similares